NMXS (Net Medical Xpress Solutions) Beginning Cash Position: $0.33 Mil (As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Net Medical Xpress Solutions Beginning Cash Position?

Net Medical Xpress Solutions NMXS +0.14% Beginning Cash Position is $0.33 Mil as of Jun. 2018.

Net Medical Xpress Solutions's Beginning Cash Position for the quarter that ended in Jun. 2018 was $0.33 Mil.

Net Medical Xpress Solutions's quarterly Beginning Cash Position declined from Sep. 2017 ($0.27 Mil) to Mar. 2018 ($0.25 Mil) but then increased from Mar. 2018 ($0.25 Mil) to Jun. 2018 ($0.33 Mil).

Net Medical Xpress Solutions's annual Beginning Cash Position declined from Dec. 2014 ($0.42 Mil) to Dec. 2015 ($0.28 Mil) but then increased from Dec. 2015 ($0.28 Mil) to Dec. 2016 ($0.41 Mil).

Net Medical Xpress Solutions Beginning Cash Position Related Terms

Net Medical Xpress Solutions Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Net Medical Xpress Solutions's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Net Medical Xpress Solutions Beginning Cash Position Chart

Net Medical Xpress Solutions Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.11 0.42 0.28 0.41

Net Medical Xpress Solutions Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Mar18 Jun18
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.27 0.27 0.25 0.33

Net Medical Xpress Solutions Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.33 Mil mean?
Net Medical Xpress Solutions (NMXS) has a Beginning Cash Position of $0.33 Mil as of Jun. 2018. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Net Medical Xpress Solutions and its competitors.
Is Net Medical Xpress Solutions' Beginning Cash Position too high?
Net Medical Xpress Solutions' current Beginning Cash Position is $0.33 Mil.
How does Net Medical Xpress Solutions' Beginning Cash Position compare to TVMD and UCBB?
Net Medical Xpress Solutions' Beginning Cash Position of $0.33 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Healthcare Providers & Services company?
A good Beginning Cash Position depends on the Healthcare Providers & Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Net Medical Xpress Solutions and its competitors. Net Medical Xpress Solutions's current Beginning Cash Position is $0.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Net Medical Xpress Solutions stock overvalued right now?
Net Medical Xpress Solutions (NMXS) has a current Beginning Cash Position of $0.33 Mil. The current Beginning Cash Position is $0.33 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Net Medical Xpress Solutions (NMXS), the current Beginning Cash Position is $0.33 Mil as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Net Medical Xpress Solutions Business Description

Address 8206 Louisiana Boulevard NE, Suite A, Albuquerque, NM, USA, 87113
Net Medical Xpress Solutions Inc is engaged in providing solutions to the telemedicine industry which deliver medical laboratory services. It offers proprietary software that links electronic medical records while enabling state-of-the-art conferencing and communications. The company's mobile fleet of vans is utilized to provide sales support for its clinical research organization. It also offers call centers, proprietary hardware implementations, diagnostic and clinical services, and software research and development capabilities.